Host genetics and immune control of HIV-1 infection: Fine mapping for the extended human MHC region in an African cohort

Genes and Immunity

Volumn 15, Issue 5, 2014, Pages 275-281

  Prentice, H A ^a,g   Pajewski, N M ^b   He, D ^a   Zhang, K ^a   Brown, E E ^a   Kilembe, W ^c   Allen, S ^c,d   Hunter, E ^e   Kaslow, R A ^a,h   Tang, J ^a,f  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Zambia Emory HIV Research Project   (Zambia)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY   (United States)

^f University of Alabama at Birmingham   (United States)

^g Military HIV Research Program   (United States)

^h DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA B57 ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; NOTCH4 RECEPTOR;

ADULT; AFRICA; ALLELE; ANALYTICAL EQUIPMENT; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOCHIP; INFECTION CONTROL; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SEROPREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; ZAMBIA; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PATHOGENICITY; AFRICAN; ANALYTIC METHOD; COHORT ANALYSIS; GENETIC ANALYSIS; HLA SYSTEM; HUMAN CELL; IMMUNOGENETICS; SEROCONVERSION;

ADULT; AFRICA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; VIRAL LOAD;

EID: 84905045508     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.16     Document Type: Article

References (61)

1. Prentice HA, Tang J. HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues. Viruses 2012; 4: 2080-2096.
2. Guergnon J, Theodorou I. What did we learn on host's genetics by studying large cohorts of HIV-1-infected patients in the genome-wide association era? Curr Opin HIV AIDS 2011; 6: 290-296.
3. Aouizerat BE, Pearce CL, Miaskowski C. The search for host genetic factors of HIV/AIDS pathogenesis in the post-genome era: progress to date and new avenues for discovery. Curr HIV/AIDS Rep 2011; 8: 38-44.
4. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317: 944-947.
5. Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML et al. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS ONE 2008; 3: e3907.
6. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O et al. Gen-omewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009; 199: 419-426.
7. Le Clerc S, Limou S, Coulonges C, Carpentier W, Dina C, Taing L et al. Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J Infect Dis 2009; 200: 1194-1201.
8. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009; 5: e1000791.
9. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS et al. Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis 2010; 201: 618-626.
10. Pelak K, Goldstein DB, Walley NM, Fellay J, Ge D, Shianna KV et al. Host determinants of HIV-1 control in African Americans. J Infect Dis 2010; 201: 1141-1149.
11. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010; 330: 1551-1557.
12. Bartha I, Carlson JM, Brumme CJ, McLaren PJ, Brumme ZL, John M et al. A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. Elife 2013; 2: e01123.
13. Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M et al. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS ONE 2008; 3: e3636.
14. Shrestha S, Aissani B, Song W, Wilson CM, Kaslow RA, Tang J. Host genetics and HIV-1 viral load set-point in African-Americans. AIDS 2009; 23: 673-677.
15. Chapman SJ, Hill AV. Human genetic susceptibility to infectious disease. Nat Rev Genet 2012; 13: 175-188.
16. Donfack J, Buchinsky FJ, Post JC, Ehrlich GD. Human susceptibility to viral infection: the search for HIV-protective alleles among Africans by means of genome-wide studies. AIDS Res Hum Retroviruses 2006; 22: 925-930.
17. McLaren PJ, Ripke S, Pelak K, Weintrob AC, Patsopoulos NA, Jia X et al. Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans. Hum Mol Genet 2012; 21: 4334-4347.
18. Tang J, Tang S, Lobashevsky E, Myracle AD, Fideli U, Aldrovandi G et al. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J Virol 2002; 76: 8276-8284.
19. Tang J, Tang S, Lobashevsky E, Zulu I, Aldrovandi G, Allen S et al. HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. AIDS Res Hum Retroviruses 2004; 20: 19-25.
20. Lazaryan A, Lobashevsky E, Mulenga J, Karita E, Allen S, Tang J et al. Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans. J Virol 2006; 80: 6056-6060.
21. Tang J, Malhotra R, Song W, Brill I, Hu L, Farmer PK et al. Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships. PLoS ONE 2010; 5: e9629.
22. Yue L, Prentice HA, Farmer P, Song W, He D, Lakhi S et al. Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection. J Virol 2012; 87: 708-715.
23. Tang J, Cormier E, Gilmour J, Price MA, Prentice HA, Song W et al. Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes. J Virol 2011; 85: 8894-8902.
24. Crawford H, Matthews PC, Schaefer M, Carlson JM, Leslie A, Kilembe W et al. The hypervariable HIV-1 capsid protein residues comprise HLA-driven CD8 + T-cell escape mutations and covarying HLA-independent polymorphisms. J Virol 2011; 85: 1384-1390.
25. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, Dilthey A et al. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet 2012; 44: 502-510.
26. Hinks A, Barton A, Shephard N, Eyre S, Bowes J, Cargill M et al. Identification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysis. Arthritis Rheum 2009; 60: 258-263.
27. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal S. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296: 1439-1443.
28. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009; 458: 641-645.
29. Prentice HA, Porter TR, Price MA, Cormier E, He D, Farmer PK et al. HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race? J Virol 2013; 87: 4043-4051.
30. Ayers KL, Cordell HJ. SNP selection in genome-wide and candidate gene studies via penalized logistic regression. Genet Epidemiol 2010; 34: 879-891.
31. Hoggart CJ, Whittaker JC, De Iorio M, Balding DJ. Simultaneous analysis of all SNPs in genome-wide and re-sequencing association studies. PLoS Genet 2008; 4: e1000130.
32. Via M, Gignoux C, Burchard EG. The 1000 Genomes Project: new opportunities for research and social challenges. Genome Med 2010; 2: 3.
33. Rosenbloom KR, Dreszer TR, Pheasant M, Barber GP, Meyer LR, Pohl A et al. ENCODE whole-genome data in the UCSC Genome Browser. Nucleic Acids Res 2010; 38(Database issue): D620-D625.
34. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74.
35. Le Clerc S, Coulonges C, Delaneau O, Van Manen D, Herbeck JT, Limou S et al. Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS. J Acquir Immune Defic Syndr 2011; 56: 279-284.
36. He C, Hamon S, Li D, Barral-Rodriguez S, Ott J. Diabetes Genetics Consortium. MHC fine mapping of human type 1 diabetes using the T1DGC data. Diabetes Obes Metab 2009; 11(Suppl 1): 53-59.
37. Valdes AM, Thomson G. Type 1 Diabetes Genetics Consortium. Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1. Diabetes Obes Metab 2009; 11(Suppl 1): 46-52.
38. Morris DL, Taylor KE, Fernando MM, Nititham J, Alarcon-Riquelme ME, Barcellos LF et al. Unraveling multiple MHC gene associations with systemic lupus erythe-matosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. Am J Hum Genet 2012; 91: 778-793.
39. Santin I, Castellanos-Rubio A, Aransay AM, Gutierrez G, Gaztambide S, Rica I et al. Exploring the diabetogenicity of the HLA-B18-DR3 CEH: independent association with T1D genetic risk close to HLA-DOA. Genes Immun 2009; 10: 596-600.
40. Souwer Y, Chamuleau ME, van de Loosdrecht AA, Tolosa E, Jorritsma T, Muris JJ et al. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival. Br J Haematol 2009; 145: 334-343.
41. Xiu F, Cô té MH, Bourgeois-Daigneault MC, Brunet A, Gauvreau ME, Shaw A et al. Cutting edge: HLA-DO impairs the incorporation of HLA-DM into exosomes. J Immunol 2011; 187: 1547-1551.
42. Dorak MT, Shao W, Machulla HK, Lobashevsky ES, Tang J, Park MH et al. Conserved extended haplotypes of the major histocompatibility complex: further characterization. Genes Immun 2006; 7: 450-467.
43. Polychronakos C. Fine points in mapping autoimmunity. Nat Genet 2011; 43: 1173-1174.
44. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A et al. Dense gen-otyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011; 43: 1193-1201.
45. Nikula T, West A, Katajamaa M, Lönnberg T, Sara R, Aittokallio T et al. A human ImmunoChip cDNA microarray provides a comprehensive tool to study immune responses. J Immunol Methods 2005; 303: 122-134.
46. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011; 13: 101.
47. Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 2001; 17: 901-910.
48. Trask SA, Derdeyn CA, Fideli U, Chen Y, Meleth S, Kasolo F et al. Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia. J Virol 2002; 76: 397-405.
49. Kempf MC, Allen S, Zulu I, Kancheya N, Stephenson R, Brill I et al. Enrollment and retention of HIV discordant couples in Lusaka, Zambia. J Acquir Immune Defic Syndr 2008; 47: 116-125.
50. Browning BL, Yu Z. Simultaneous genotype calling and haplotype phasing improves genotype accuracy and reduces false-positive associations for genome-wide association studies. Am J Hum Genet 2009; 85: 847-861.
51. de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J et al. A highresolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006; 38: 1166-1172.
52. Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen WM. Robust relationship inference in genome-wide association studies. Bioinformatics 2010; 26: 2867-2873.
53. Manichaikul A, Palmas W, Rodriguez CJ, Peralta CA, Divers J, Guo X et al. Population structure of Hispanics in the United States: the multi-ethnic study of atherosclerosis. PLoS Genet 2012; 8: e1002640.
54. Zhu X, Li S, Cooper RS, Elston RC. A unified association analysis approach for family and unrelated samples correcting for stratification. Am J Hum Genet 2008; 82: 352-365.
55. International HapMap 3 Consortium, Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467: 52-58.
56. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
57. Vignal CM, Bansal AT, Balding DJ. Using penalised logistic regression to fine map HLA variants for rheumatoid arthritis. Ann Hum Genet 2011; 75: 655-664.
58. Gao X, Starmer J, Martin ER. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 2008; 32: 361-369.
59. Gao X, Becker LC, Becker DM, Starmer JD, Province MA. Avoiding the high Bon-ferroni penalty in genome-wide association studies. Genet Epidemiol 2010; 34: 100-105.
60. Tang J, Shao W, Yoo YJ, Brill I, Mulenga J, Allen S et al. Human leukocyte antigen class I genotyes in relation to heterosexual HIV type 1 transmission within discordant couples. J Immunol 2008; 181: 2626-2635.
61. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012; 40(Database issue): D930-D934.